Joel Schilling

Medicine & Life Sciences

1. Allografts 9%
2. Antibodies 11%
3. Autophagy 31%
4. Bacteria 11%
5. Bacterial Fimbriae 20%
6. Cardiomyopathies 20%
7. Cell Death 11%
8. Diabetic Cardiomyopathies 17%
9. Epithelial Cells 17%
10. ERRalpha estrogen-related receptor 13%
11. Escherichia coli 15%
12. Fatty Acids 14%
13. Fatty Liver 19%
14. Heart 41%
15. Heart Failure 31%
16. Heart Transplantation 19%
17. Heart-Assist Devices 70%
18. High-Protein Diet 15%
19. Host-Pathogen Interactions 10%
20. Infections 13%
21. Inflammasomes 27%
22. Inflammation 23%
23. Interleukin-1 17%
24. Lipids 16%
25. Lipopolysaccharides 21%
26. Liver 14%
27. Lysosomes 33%
28. Macrophage Activation 26%
29. Macrophages 100%
30. Mitochondria 14%
31. Mortality 12%
32. Non-alcoholic Fatty Liver Disease 10%
33. Obesity 10%
34. Organelles 11%
35. Palmitates 21%
36. Peroxisome Proliferator-Activated Receptors 16%
37. Phenotype 12%
38. Primary Graft Dysfunction 19%
39. Pulmonary Hypertension 10%
40. Right Ventricular Dysfunction 15%
41. Survival 16%
42. Toll-Like Receptor 4 12%
43. Toll-Like Receptors 11%
44. Transcription Factors 11%
45. Transplant Recipients 14%
46. Transplants 33%
47. Trehalose 9%
48. Urinary Bladder 40%
49. Urinary Tract Infections 32%
50. Uropathogenic Escherichia coli 54%